CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
Explore some of the common pitfalls witnessed in healthcare environments, as well as guidance for implementing a penetration testing program.
ECOA RESOURCES
-
The value of eCOA tools is undisputed, but using a waterfall methodology of software delivery is highly inefficient. Explore how a more agile approach to eCOA development can produce a fully functional eCOA in a day.
-
With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.
-
Discover new possibilities where patients can complete several of their clinical study procedures remotely, making their participation in clinical trials easier and less cumbersome than site-based trials.
ECONSENT RESOURCES
-
eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.
-
Electronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.
-
Effortlessly conduct multi-center clinical trials worldwide for drug development with Castor’s EDC and CDMS platforms, including eCOA, ePRO, EHR eSource, eConsent, and IRT modules.
EPRO RESOURCES
-
With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.
-
In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.
-
Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.